U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors

Haemophilia

Volumn 18, Issue 3, 2012, Pages 400-405

  Shapiro, A ^a   Cooper, D L ^b  

^a INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^b NOVO NORDISK INC   (United States)

Author keywords

Haemophilia; Haemophilia treatment centres; Inhibitors; Orthopaedic surgery; Surgery

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8; FIBRIN GLUE; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABDOMINAL SURGERY; ARTHRODESIS; ARTHROSCOPY; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR SURGERY; CENTRAL VENOUS CATHETERIZATION; CLINICAL PROTOCOL; DENTAL SURGERY; EXPERIENCE; FRACTURE FIXATION; HEALTH SURVEY; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HOSPITAL; HUMAN; JOINT PROSTHESIS; MEDICAL PRACTICE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOISOTOPE THERAPY; SURGICAL TECHNIQUE; SYNOVECTOMY; UNITED STATES;

ADOLESCENT; ATTITUDE OF HEALTH PERSONNEL; BLOOD COAGULATION FACTOR INHIBITORS; CHILD; CHILD, PRESCHOOL; CLINICAL COMPETENCE; HEALTH SURVEYS; HEMOPHILIA A; HEMOPHILIA B; HUMANS; INFANT; INFANT, NEWBORN; QUESTIONNAIRES; SURGICAL PROCEDURES, OPERATIVE; UNITED STATES; YOUNG ADULT;

EID: 84860316527     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02698.x     Document Type: Article

References (18)

1. Ehrenforth S, Kreuz W, Scharrer I et al. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992; 339: 594-8.
2. Darby SC, Keeling DM, Spooner RJD, Giangrande PLF, Collins PW, Hill FG. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost 2004; 2: 1047-54.
3. CDC (Centers for Disease Control and Prevention). Hemophilia facts. Available at Accessed January 31, 2011.
4. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80: 773-8.
5. Pruthi RK, Mathew P, Valentino LA et al. Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial. Thromb Haemost 2007; 98: 726-32.
6. Serban M, Poenaru D, Pop L et al. Surgery - a challenge in haemophiliacs with inhibitors. Hamostaseologie 2009; 29(suppl 1): S39-41.
7. Jiménez-Yuste V, Rodriguez-Merchan EC, Alvarez MT, Quintana M, Fernandez Hernandez-Navarro F. Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors. Semin Hematol 2008; 45(2 suppl 1): S64-7.
8. Obergfell A, Auvinen MK, Mathew P. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature. Haemophilia 2008; 14: 233-41.
9. Solimeno LP, Mancuso ME, Pasta G, Santagostino E, Perfetto S, Mannucci PM. Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs: a review of 116 procedures at a single institution. Br J Haematol 2009; 145: 227-34.
10. Boadas A, Fernández-Palazzi F, De Bosch BD, Cedeño M, Ruiz-Sáez A. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela. Haemophilia 2011; 17: 422-7.
11. Takedani H, Kawahara H, Kajiwara M. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa. Haemophilia 2010; 16: 290-5.
12. Balkan C, Karapinar D, Aydogdu S et al. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience. Haemophilia 2010; 16: 902-9.
13. Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia 2011; 17: 910-9.
14. Rodriguez-Merchan EC, Jimenez-Yuste V, Gomez-Cardero P, Alvarez-Roman M, Martin-Salces M, Rodriguez de la Rua A. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience. Haemophilia 2010; 16: 84-8.
15. Quintana-Molina M, Martínez-Bahamonde F, González-García E et al. Surgery in haemophilic patients with inhibitor: 20years of experience. Haemophilia 2004; 10(suppl 2): 30-40.
16. Giangrande PL, Wilde JT, Madan B et al. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. J Haemophilia 2009; 15: 501-8.
17. Teitel JM, Carcao M, Lillicrap D et al. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Haemophilia 2009; 15: 227-39.
18. Centers for Disease Control and Prevention (CDC). Universal Data Collection Summary Report. Available at Accessed September 29, 2010.